Hanyi Biotechnology

Hanyi Biotechnology is a leading Chinese biopharmaceutical company specializing in the research, development, and industrialization of medical cannabis and cannabinoid-based therapies. The company operates a comprehensive industrial chain that includes cultivation, extraction, and drug development, focusing on cannabinoids such as cannabidiol (CBD) and cannabigerol (CBG). Hanyi's research is primarily directed toward treating neurological disorders, chronic pain, and inflammatory conditions. The company has established a robust pipeline with candidates targeting indications like epilepsy and Parkinson's disease. By integrating traditional botanical knowledge with modern biotechnology, Hanyi aims to lead the medical cannabis industry in Asia and beyond.